Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis

2019309 citationsReviewhybrid Open Access

Authors

Sarah Burdett · MRC Clinical Trials Unit at UCL

Liselotte M.S. Boevé · Vrije Universiteit Amsterdam

Fiona C. Ingleby · University College London

David J. Fisher · MRC Clinical Trials Unit at UCL

Larysa Rydzewska · University College London

Claire L. Vale · University College London

George van Andel

Abstract

Prostate cancer that has spread to other parts of the body (metastases) is usually treated with hormone therapy. In men with fewer than five bone metastases, addition of prostate radiotherapy helped them live longer and should be considered.

Topics & Keywords

Prostate Cancer Treatment and Research Prostate Cancer Diagnosis and Treatment Statistical Methods in Clinical Trials

Publication Details

Published in: European Urology

Volume 76, Issue 1, pp. 115-124

DOI: 10.1016/j.eururo.2019.02.003

Field-Weighted Citation Impact: 28.77

Command Palette

Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis

Authors

Abstract

Topics & Keywords

Publication Details